Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease
about
Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation.Oxytocin and cardioprotection in diabetes and obesityMechanoresponsive musculoskeletal tissue differentiation of adipose-derived stem cellsProangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic ApplicationsTranslational research of adult stem cell therapyStem cell therapy for CHD: towards translationAutologous Stem Cell Therapy: How Aging and Chronic Diseases Affect Stem and Progenitor CellsCardiac stem cells: biology and clinical applicationsCardiac side population cells: moving toward the center stage in cardiac regenerationEmerging Applications of Stem Cell and Regenerative Medicine to Sports InjuriesUse of mesenchymal stem cells for therapy of cardiac diseaseOrigin of cardiomyocytes in the adult heartParacrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine heartsIntrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysisProstacyclin-producing human mesenchymal cells target H19 lncRNA to augment endogenous progenitor function in hindlimb ischaemia.Genetically modified mesenchymal stromal cells in cancer therapyCardiac Regenerative Medicine: The Potential of a New Generation of Stem CellsDevelopmental origin and lineage plasticity of endogenous cardiac stem cellsMesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic NephropathyIntrapericardial Delivery of Cardiosphere-Derived Cells: An Immunological Study in a Clinically Relevant Large Animal ModelActivation of regulatory T cells during inflammatory response is not an exclusive property of stem cellsAdult human nasal mesenchymal-like stem cells restore cochlear spiral ganglion neurons after experimental lesion.Diabetes-associated macrovascular complications: cell-based therapy a new tool?Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells.Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms.Integral role of platelet-derived growth factor in mediating transforming growth factor-β1-dependent mesenchymal stem cell stiffening.Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.Rapid fusion between mesenchymal stem cells and cardiomyocytes yields electrically active, non-contractile hybrid cellsIdentification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells.Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model.Bone marrow-derived mesenchymal stem cells overexpressing MiR-21 efficiently repair myocardial damage in ratsMesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia.Enhanced Cardioprotection by Human Endometrium Mesenchymal Stem Cells Driven by Exosomal MicroRNA-21.Targeted Genome Engineering to Control VEGF Expression in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells: Potential Implications for the Treatment of Myocardial Infarction.Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Inflammatory Bowel Disease in Mice.Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.Molecular and cellular basis of viable dysfunctional myocardium.Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege.
P2860
Q24595801-BB09803E-F017-4B15-A8F8-D643C9A15649Q26748592-476B7EA8-0778-4831-8551-F054557270F4Q26751173-020CCA5A-6A00-4632-94CF-0D7B44533004Q26765924-9D78965B-3197-4CE6-8A01-37D2E00A306BQ26774565-348C4A34-F4ED-4576-930F-D98D2969E861Q26786034-02FD191B-4E2E-4F98-BBCC-73990CB83D6EQ26796809-17FFA8FD-910E-4624-B57B-B28DA3895F94Q26825051-2D62F95E-D3DA-4DDD-87BC-B8B9DE9EE3A5Q26862552-D554C830-923F-48D6-8E1E-2A4D18A233B7Q26991609-7898FA40-B0F9-44DF-8D69-24189E7F9DE5Q27003127-3AB2BE45-5C69-4177-A0DC-8E27C396D917Q27023325-55B62202-2C14-4EB9-A14E-F7F7BF4C569DQ27304850-DFEC6439-696E-4DF2-B26B-B5D7082C4EC0Q27310275-72E93B7B-ABC7-4117-98A2-1FE39C29408EQ27320117-979A433A-4228-451B-B240-0EFFF6B8A8E6Q28071840-F7AEA2BD-D9EA-44B3-A1DC-04B9412F194CQ28079057-7675C351-0B3E-44AC-9219-9328DE3EF0A4Q28080127-F40AC9A9-CD0E-454D-A6C0-3AA628557680Q28354224-2986757B-FD6A-4349-B63D-24A6393C4419Q28550109-171974C8-3A6F-4C4E-A6B4-FA83D565DDF2Q28730432-D552FBC0-C342-4AFC-8F17-9CDA72E1AA28Q30417871-BB2A4B84-40EC-4975-99F0-DBD187ED0004Q30428895-57AAA2F9-741B-49DD-A1CF-46AE7355A2A9Q30539770-C3E638EE-4C67-4FE5-A37E-BBE31AB27F10Q30557136-78C3AC6F-F160-42EE-999A-792A04B376F3Q30569752-0411CE76-CF10-46AF-B74B-001E21C7E5C6Q30581265-A039A09F-8E61-4658-A306-87D79C5E11C9Q30657408-E43587DE-44FA-42DD-864D-C7E2DBC374A7Q31068753-23EA83B3-C4F6-4E3E-9E5B-6B5EA73706F1Q33577748-55800FCA-85E3-4E9C-BE40-8592ECC4625BQ33710055-32B0D898-7500-4676-BDAD-B63EE2581DABQ33719419-C2DD2CF8-4D3A-4091-82B5-211623A64680Q33722124-41BEECD0-B903-4BD0-8A0E-3515E11F8294Q33722181-3B877175-D6BA-46CD-8D83-BA3648F5B6A5Q33722274-2DEA294E-8C5A-48E9-9D30-1BE871BDC8BEQ33735563-04EB02C8-2000-459F-82DA-3A3C568C739BQ33745962-49510CEF-51D7-48CF-9790-EDAD7A9AF421Q33924001-7A5B17EA-143E-419F-BF15-94AC93B0DB00Q33950809-9E16F3B2-B75C-4A42-A93E-A66BF9332EF3Q33985624-DFA5F89C-2E6A-41B4-8EEE-CD8744287A65
P2860
Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@ast
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@en
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@nl
type
label
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@ast
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@en
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@nl
prefLabel
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@ast
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@en
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@nl
P2860
P3181
P1433
P1476
Mesenchymal stem cells: biolog ...... plications for cardiac disease
@en
P2093
A. R. Williams
J. M. Hare
P2860
P304
P3181
P356
10.1161/CIRCRESAHA.111.243147
P407
P577
2011-09-30T00:00:00Z